Clinical Trial Update: Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a DHA-rich supplement's effect on DHA status and overall health in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• DHA-rich supplement (docosahexaenoic acid supplement)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED